----
Current ValuationThe current P/E ratio is 64.88, within the reasonable range, cheaper than 24.17% of the time in the past 3 years, and the industry ranks 123/223, the industry Median 21.68.
64.88xP/E
¥40.87Stock price
¥0.63Earnings per share
64.88xP/E
Stock price¥40.87Earnings per share¥0.63
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 51.61x
- Typical range
- 44.17x–66.17x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 21.68x
017345168
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 21.68x
0x40x80x120x160x200x
| Name/Symbol | |||
|---|---|---|---|
300558SZBETTA PHARMACEUTICALS | 64.88x | 90.41% | ¥17.30B |
301569SZNOVAST | 63.68x | -- | ¥16.92B |
603858SHBUCHANG PHARMA | 65.51x | -- | ¥15.44B |
002399SZHepalink | 66.60x | 109.91% | ¥13.51B |
002755SZASK PHARM | 62.19x | -- | ¥11.36B |
300049SZFurui Co.,Ltd. | 61.11x | 75.86% | ¥10.15B |
300702SZTIANYU PHARM | 79.29x | 121.95% | ¥7.18B |
603538SHMenovo | 60.65x | -- | ¥7.09B |
688553SHHUIYU PHARMACEUTICAL | 60.54x | -- | ¥6.87B |
603229SHAusun Pharm | 75.08x | 106.25% | ¥6.09B |
002907SZPharscin Pharma | 60.48x | -- | ¥5.68B |
002728SZTY PHAR. | 67.53x | 181.25% | ¥4.45B |
301281SZKeyuan Pharma | 62.81x | -- | ¥4.42B |
600628SHSNW | 62.07x | -- | ¥4.26B |
002644SZFoci Pharmaceutical | 61.43x | -- | ¥3.80B |
600222SHTaloph | 69.76x | -- | ¥3.68B |
002365SZYONGAN PHARMACEUTICAL | 62.30x | -- | ¥3.33B |
301509SZKingchem | 68.68x | -- | ¥3.10B |
301331SZENWEI PHARMACEUTICAL | 60.64x | -- | ¥2.29B |
603079SHSHENGDA BIO-PHARM | 65.45x | -- | ¥2.22B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
